Health Care·Health Care Supplies·$12.6B
Cooper Cos Inc (COO) operates in the health care sector, focusing on health care supplies, particularly in the contact lens market. As a significant player in this industry, the company's performance can be influenced by trends in consumer health and spending, as well as advancements in medical technology.
Earnings Per Share (EPS)
EPS is a key indicator of profitability and helps investors gauge the company's financial health.
Revenue Growth
Revenue growth reflects the company's ability to expand its market share and increase sales, which is crucial for long-term success.
1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
8Q
EPS Beat Rate
100%
Avg EPS Surprise
+38.00%
Avg Stock Reaction
-0.40%
In the last quarter, Cooper Cos reported an EPS of $1.18, exceeding expectations by 14.79%. Despite this positive surprise, the stock experienced a slight decline of 2.17% the following day.
Management Promises & Guidance
Overall, expectations for Cooper Cos are mixed, with some investors optimistic about continued EPS growth while others are cautious due to potential market challenges.
Bull Case
The bull case hinges on strong demand for contact lenses and effective cost management, which could lead to higher-than-expected EPS and revenue growth.
Bear Case
Conversely, the bear case suggests that rising competition and potential supply chain issues could hinder growth, leading to disappointing financial results.
Earnings Per Share (EPS)
N/AEPS is a key indicator of profitability and helps investors gauge the company's financial health.
Revenue Growth
N/ARevenue growth reflects the company's ability to expand its market share and increase sales, which is crucial for long-term success.
Market Demand for Contact Lenses
N/AUnderstanding market demand can provide insights into future sales and profitability, especially in a competitive landscape.
The print will turn on these two things.
Q1
What is the expected EPS for this quarter, and how does it compare to last quarter's performance?
Given the company's history of beating EPS estimates, this figure will be crucial for investor sentiment and stock performance.
Q2
How is Cooper Cos addressing competitive pressures in the contact lens market?
Understanding the company's strategy in a competitive landscape will help assess its ability to maintain or grow market share.
Why consensus could be wrong
The market may be underestimating the potential for Cooper Cos to capitalize on new product launches, which could drive stronger-than-expected sales.
Supporting Evidence
The company has consistently beaten EPS estimates, indicating a trend of positive performance.
Options pricing suggests a significant move, which may not align with the cautious sentiment reflected in stock performance.
The put/call ratio indicates a higher level of hedging, suggesting that some investors are bracing for potential downside.
Key Risk
If the company announces a new product line that significantly boosts sales, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
This quarter's results are critical as they will reveal how well Cooper Cos is navigating market challenges and capitalizing on growth opportunities.
Bull Confirmed If
An EPS of $1.25 or higher would confirm the bull case, indicating strong demand and effective cost management.
Bear Confirmed If
An EPS below $1.00 would support the bear case, suggesting that competitive pressures are impacting profitability.
Implied Move
±11.71%
Historical Avg
±0.9%
The options market is pricing in a significant move, indicating that investors expect volatility around the earnings announcement.
Options are pricing ±11.7% while COO has averaged ±0.9% over the last 8 prints — setup is pricing rich.
Likely market behavior by outcome — not investment advice.
Beat & Raise
If Cooper Cos beats expectations, history suggests the stock could see a positive reaction, potentially around a 0.95% increase, confirming strong market demand.
In-Line / Cautious
If results are in line with expectations, the stock may experience muted movement as investors await further guidance from management.
Miss
Should the company miss expectations, history suggests a potential decline of around 0.40%, indicating investor disappointment.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
GRUPO FINANCIERO GAL B ADR
May 26, 2026